SAVE THE DATE! The 6th World Consensus Conference on BIA-ALCL will be held April 11-12, 2025, and will feature leading experts in breast surgery and implant safety discussing the latest research on breast implant-associated cancers.

The FDA plays a major role in deciding which medical devices are safe, but who ensures that patient voices are heard in those decisions? BISA’s own Maria Gmitro has been appointed as a Consumer Representative for the FDA, bringing real-world patient perspectives to the table. Read on to find out why this is a major win for patient advocacy!

On February 6, 2025, the FDA provided updates on the safety and effectiveness of breast implants. BISA provides a brief summary and why this info is crucial for the public.

Every woman is at risk for breast cancer. You never know when you or someone you love will be faced with decisions about breast implants. We want to keep you safe, healthy and informed with information you can trust. KNOWLEDGE IS BEAUTIFUL

Save the date for the 10th International Breast Surgery Workshop (IBSW) and the 6th World Consensus Conference on BIA-ALCL, scheduled for April 11-12, 2025, in Tampa, Florida,

Maria Gmitro of Breast Implant Safety Alliance (BISA) addresses breast implant related illness and cancers, BIA-ALCL, and BIA-SCC with a focus on informed consent and her personal experience with breast implants, advocacy and the FDA.